Lazard Asset Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Lazard Asset Management’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,813	Closed	-$4K	–	2619
2022 Q1	$4K	Hold	7,813	–	–	﹤0.01%	2208
2021 Q4	$8K	Sell	7,813 -1,953	-20%	-$3.02K	﹤0.01%	2144
2021 Q3	$18K	Hold	9,766	–	–	﹤0.01%	2034
2021 Q2	$30K	Sell	9,766 -3,906	-29%	-$9.76K	﹤0.01%	1773
2021 Q1	$44K	Buy	+13,672	New	+$49.5K	﹤0.01%	1504

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lazard Asset Management's ASXC Position: Q2 2022 in Review

Lazard Asset Management sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 7,813 shares — an estimated $4K sold.

Lazard Asset Management first reported a position in ASXC in Q1 2021 and held it in 5 quarters. The position peaked at $44K in Q1 2021. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

Lazard Asset Management reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
Lazard Asset Management sold 7,813 Asensus Surgical, Inc. shares in Q2 2022, an estimated $4K.
Lazard Asset Management first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 5 quarters.
Lazard Asset Management's Asensus Surgical, Inc. position peaked at $44K in Q1 2021.
91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.